Connection
David Simpson to Acquired Immunodeficiency Syndrome
This is a "connection" page, showing publications David Simpson has written about Acquired Immunodeficiency Syndrome.
|
|
Connection Strength |
|
 |
|
 |
|
2.970 |
|
|
|
-
Gonzalez-Duarte A, Sullivan S, Sips GJ, Naidich T, Kleinman G, Murray J, Morgello S, Germano I, Mullen M, Simpson D. Inflammatory pseudotumor associated with HIV, JCV, and immune reconstitution syndrome. Neurology. 2009 Jan 20; 72(3):289-90.
Score: 0.288
-
Di Rocco A, Werner P, Bottiglieri T, Godbold J, Liu M, Tagliati M, Scarano A, Simpson D. Treatment of AIDS-associated myelopathy with L-methionine: a placebo-controlled study. Neurology. 2004 Oct 12; 63(7):1270-5.
Score: 0.214
-
Williams D, Geraci A, Simpson DM. AIDS and AIDS-treatment neuropathies. Curr Pain Headache Rep. 2002 Apr; 6(2):125-30.
Score: 0.180
-
Williams D, Geraci A, Simpson DM. AIDS and AIDS-treatment neuropathies. Curr Neurol Neurosci Rep. 2001 Nov; 1(6):533-8.
Score: 0.175
-
Wulff EA, Simpson DM. Peripheral neuropathy associated with acquired immunodeficiency syndrome (AIDS)-related Burkitt's lymphoma. Muscle Nerve. 2000 Nov; 23(11):1764-6.
Score: 0.163
-
Tagliati M, Di Rocco A, Danisi F, Simpson DM. The role of somatosensory evoked potentials in the diagnosis of AIDS-associated myelopathy. Neurology. 2000 Apr 11; 54(7):1477-82.
Score: 0.157
-
Di Rocco A, Tagliati M, Danisi F, Dorfman D, Moise J, Simpson DM. A pilot study of L-methionine for the treatment of AIDS-associated myelopathy. Neurology. 1998 Jul; 51(1):266-8.
Score: 0.139
-
Berger JR, Simpson DM. The pathogenesis of diffuse infiltrative lymphocytosis syndrome: an AIDS-related peripheral neuropathy. Neurology. 1998 Apr; 50(4):855-7.
Score: 0.136
-
Simpson DM, Slasor P, Dafni U, Berger J, Fischl MA, Hall C. Analysis of myopathy in a placebo-controlled zidovudine trial. Muscle Nerve. 1997 Mar; 20(3):382-5.
Score: 0.126
-
Simpson DM, Dorfman D, Olney RK, McKinley G, Dobkin J, So Y, Berger J, Ferdon MB, Friedman B. Peptide T in the treatment of painful distal neuropathy associated with AIDS: results of a placebo-controlled trial. The Peptide T Neuropathy Study Group. Neurology. 1996 Nov; 47(5):1254-9.
Score: 0.124
-
Simpson DM, Tagliati M. Neurologic manifestations of HIV infection. Ann Intern Med. 1994 Nov 15; 121(10):769-85.
Score: 0.108
-
Simpson DM, Tagliati M, Ramcharitar S. Neurologic complications of AIDS: new concepts and treatments. Mt Sinai J Med. 1994 Nov; 61(6):484-91.
Score: 0.108
-
Morgello S, Simpson DM. Multifocal cytomegalovirus demyelinative polyneuropathy associated with AIDS. Muscle Nerve. 1994 Feb; 17(2):176-82.
Score: 0.102
-
Simpson DM, Citak KA, Godfrey E, Godbold J, Wolfe DE. Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished? Neurology. 1993 May; 43(5):971-6.
Score: 0.097
-
Hightower GK, Wong JK, Letendre SL, Umlauf AA, Ellis RJ, Ignacio CC, Heaton RK, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Grant I, Little SJ, Richman DD, Kosakovsky Pond SL, Smith DM. Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment. Virology. 2012 Nov 25; 433(2):498-505.
Score: 0.093
-
Birbeck GL, French JA, Perucca E, Simpson DM, Fraimow H, George JM, Okulicz JF, Clifford DB, Hachad H, Levy RH. Antiepileptic drug selection for people with HIV/AIDS: evidence-based guidelines from the ILAE and AAN. Epilepsia. 2012 Jan; 53(1):207-14.
Score: 0.088
-
Maw RD, Connolly JH, Mayne EE, McClelland W, Dinsmore WW, Horner T, Boyd JS, Colhoun HM, Doherty L, Simpson DM. Human immunodeficiency virus infection in Northern Ireland 1980-1989. Ulster Med J. 1991 Apr; 60(1):63-74.
Score: 0.084
-
Simpson DM. Myopathy associated with human immunodeficiency virus (HIV) but not with zidovudine. Ann Intern Med. 1988 Nov 15; 109(10):842.
Score: 0.071
-
Ellis RJ, Marquie-Beck J, Delaney P, Alexander T, Clifford DB, McArthur JC, Simpson DM, Ake C, Collier AC, Gelman BB, McCutchan JA, Morgello S, Grant I. Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy. Ann Neurol. 2008 Nov; 64(5):566-72.
Score: 0.071
-
Simpson DM, Bender AN. Human immunodeficiency virus-associated myopathy: analysis of 11 patients. Ann Neurol. 1988 Jul; 24(1):79-84.
Score: 0.069
-
Letendre SL, Marquie-Beck J, Ellis RJ, Woods SP, Best B, Clifford DB, Collier AC, Gelman BB, Marra C, McArthur JC, McCutchan JA, Morgello S, Simpson D, Alexander TJ, Durelle J, Heaton R, Grant I. The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system. J Neuroimmune Pharmacol. 2007 Mar; 2(1):120-7.
Score: 0.062
-
Polydefkis M, Yiannoutsos CT, Cohen BA, Hollander H, Schifitto G, Clifford DB, Simpson DM, Katzenstein D, Shriver S, Hauer P, Brown A, Haidich AB, Moo L, McArthur JC. Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology. 2002 Jan 08; 58(1):115-9.
Score: 0.044
-
Geraci A, Di Rocco A, Liu M, Werner P, Tagliati M, Godbold J, Simpson D, Morgello S. AIDS myelopathy is not associated with elevated HIV viral load in cerebrospinal fluid. Neurology. 2000 Aug 08; 55(3):440-2.
Score: 0.040
-
Chong J, Di Rocco A, Tagliati M, Danisi F, Simpson DM, Atlas SW. MR findings in AIDS-associated myelopathy. AJNR Am J Neuroradiol. 1999 Sep; 20(8):1412-6.
Score: 0.038
-
Simpson D. HIV rounds at Cornell: selected neurologic complications of HIV disease. AIDS Patient Care STDS. 1998 Mar; 12(3):209-15.
Score: 0.034
-
Tagliati M, Simpson D, Morgello S, Clifford D, Schwartz RL, Berger JR. Cerebellar degeneration associated with human immunodeficiency virus infection. Neurology. 1998 Jan; 50(1):244-51.
Score: 0.033
-
Dorfman D, DiRocco A, Simpson D, Tagliati M, Tanners L, Moise J. Oral methionine may improve neuropsychological function in patients with AIDS myelopathy: results of an open-label trial. AIDS. 1997 Jul; 11(8):1066-7.
Score: 0.032
-
Berger JR, Pall L, Hall CD, Simpson DM, Berry PS, Dudley R. Oxandrolone in AIDS-wasting myopathy. AIDS. 1996 Dec; 10(14):1657-62.
Score: 0.031
-
Birbeck GL, French JA, Perucca E, Simpson DM, Fraimow H, George JM, Okulicz JF, Clifford DB, Hachad H, Levy RH. Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy. Neurology. 2012 Jan 10; 78(2):139-45.
Score: 0.022
-
Simpson DM, Bender AN, Farraye J, Mendelson SG, Wolfe DE. Human immunodeficiency virus wasting syndrome may represent a treatable myopathy. Neurology. 1990 Mar; 40(3 Pt 1):535-8.
Score: 0.019
-
Snider WD, Simpson DM, Nielsen S, Gold JW, Metroka CE, Posner JB. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol. 1983 Oct; 14(4):403-18.
Score: 0.012
-
Jacobson JM, Spritzler J, Fox L, Fahey JL, Jackson JB, Chernoff M, Wohl DA, Wu AW, Hooton TM, Sha BE, Shikuma CM, MacPhail LA, Simpson DM, Trapnell CB, Basgoz N. Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group. J Infect Dis. 1999 Jul; 180(1):61-7.
Score: 0.009
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|